(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
Live Chart Being Loaded With Signals
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific...
Stats | |
---|---|
आज की मात्रा | 360 206 |
औसत मात्रा | 542 498 |
बाजार मूल्य | 26.59B |
EPS | $1.830 ( 2024-04-25 ) |
अगली कमाई की तारीख | ( $1.820 ) 2024-07-25 |
Last Dividend | $0.200 ( 2023-11-07 ) |
Next Dividend | $0 ( N/A ) |
P/E | 48.09 |
ATR14 | $0.192 (0.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-23 | Pucci Paolo | Buy | 564 | Common Stock |
2024-04-23 | Michels Douglas A | Buy | 564 | Common Stock |
2024-04-23 | Lai Goldman Myla | Buy | 564 | Common Stock |
2024-04-23 | Lockhart Stephen H | Buy | 564 | Common Stock |
2024-04-23 | Keller Deborah L | Buy | 564 | Common Stock |
INSIDER POWER |
---|
-9.46 |
Last 100 transactions |
Buy: 235 088 | Sell: 288 836 |
मात्रा सहसंबंध
West Pharmaceutical सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
West Pharmaceutical सहसंबंध - मुद्रा/वस्त्र
West Pharmaceutical वित्तीय
Annual | 2023 |
राजस्व: | $2.95B |
सकल लाभ: | $1.13B (38.28 %) |
EPS: | $7.99 |
FY | 2023 |
राजस्व: | $2.95B |
सकल लाभ: | $1.13B (38.28 %) |
EPS: | $7.99 |
FY | 2022 |
राजस्व: | $2.89B |
सकल लाभ: | $1.14B (39.36 %) |
EPS: | $7.88 |
FY | 2021 |
राजस्व: | $2.83B |
सकल लाभ: | $1.18B (41.52 %) |
EPS: | $8.96 |
Financial Reports:
No articles found.
West Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.180 (N/A) |
$0.190 (N/A) |
$0.190 (N/A) |
$0.190 (N/A) |
$0.190 (N/A) |
$0.200 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0163 | 1987-01-26 |
Last Dividend | $0.200 | 2023-11-07 |
Next Dividend | $0 | N/A |
Payout Date | 2023-11-15 | |
Next Payout Date | N/A | |
# dividends | 148 | -- |
Total Paid Out | $11.05 | -- |
Avg. Dividend % Per Year | 0.18% | -- |
Score | 5.52 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.83 | |
Div. Directional Score | 9.81 | -- |
Year | Amount | Yield |
---|---|---|
1987 | $0.0676 | 1.90% |
1988 | $0.0726 | 1.70% |
1989 | $0.0776 | 1.97% |
1990 | $0.100 | 2.12% |
1991 | $0.100 | 3.30% |
1992 | $0.100 | 2.19% |
1993 | $0.103 | 1.82% |
1994 | $0.113 | 1.84% |
1995 | $0.123 | 1.79% |
1996 | $0.133 | 2.23% |
1997 | $0.143 | 2.04% |
1998 | $0.153 | 2.06% |
1999 | $0.163 | 1.86% |
2000 | $0.173 | 2.28% |
2001 | $0.183 | 2.98% |
2002 | $0.190 | 2.85% |
2003 | $0.203 | 3.29% |
2004 | $0.213 | 2.49% |
2005 | $0.225 | 1.78% |
2006 | $0.245 | 1.89% |
2007 | $0.265 | 1.04% |
2008 | $0.285 | 1.41% |
2009 | $0.305 | 1.60% |
2010 | $0.325 | 1.65% |
2011 | $0.345 | 1.65% |
2012 | $0.365 | 1.91% |
2013 | $0.385 | 1.39% |
2014 | $0.410 | 0.84% |
2015 | $0.450 | 0.86% |
2016 | $0.490 | 0.85% |
2017 | $0.530 | 0.63% |
2018 | $0.570 | 0.57% |
2019 | $0.610 | 0.63% |
2020 | $0.650 | 0.43% |
2021 | $0.690 | 0.24% |
2022 | $0.730 | 0.16% |
2023 | $0.770 | 0.33% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
ZTR | Dividend Royal | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.194 | 1.500 | 6.12 | 9.17 | [0 - 0.5] |
returnOnAssetsTTM | 0.158 | 1.200 | 4.74 | 5.69 | [0 - 0.3] |
returnOnEquityTTM | 0.204 | 1.500 | 8.85 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.101 | -1.000 | 8.99 | -8.99 | [0 - 1] |
currentRatioTTM | 2.61 | 0.800 | 1.946 | 1.556 | [1 - 3] |
quickRatioTTM | 1.736 | 0.800 | 4.49 | 3.59 | [0.8 - 2.5] |
cashRatioTTM | 0.928 | 1.500 | 5.95 | 8.93 | [0.2 - 2] |
debtRatioTTM | 0.0851 | -1.500 | 8.58 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 76.61 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 10.29 | 2.00 | 6.57 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.25 | 2.00 | 7.37 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.114 | -1.500 | 9.54 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.372 | 1.000 | 7.14 | 7.14 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.220 | 1.000 | 7.61 | 7.61 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 2.47 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.813 | 0.800 | 7.91 | 6.33 | [0.5 - 2] |
Total Score | 12.80 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 47.18 | 1.000 | 5.34 | 0 | [1 - 100] |
returnOnEquityTTM | 0.204 | 2.50 | 9.26 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.25 | 2.00 | 8.25 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.216 | 1.500 | 4.59 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 10.29 | 2.00 | 6.57 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.101 | 1.500 | 8.99 | -8.99 | [0 - 1] |
pegRatioTTM | 7.55 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.258 | 1.000 | 6.04 | 0 | [0.1 - 0.5] |
Total Score | 6.83 |
West Pharmaceutical
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं